Drug Combo Lowers Albuminuria in High-Risk Chronic Kidney Disease

(MedPage Today) — HOUSTON — Adding an investigational nonsteroidal mineralocorticoid receptor antagonist (MRA) to an SGLT2 inhibitor led to a superior reduction in albuminuria among chronic kidney disease patients at risk for kidney failure…

Source link : https://www.medpagetoday.com/meetingcoverage/asn/118439

Author :

Publish date : 2025-11-11 15:58:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Drug Combo Lowers Albuminuria in High-Risk Chronic Kidney Disease

Oxfordshire TikTok creator ‘so sorry’ over cancer diagnosis lie

Women have supercharged immune systems and we now know why

Related Posts

Biomass Cooking Pollution Not Linked to Pneumonia in Infants

Automatic Doors May Raise Risk for Injury Among Older Adults

GLP-1 RAs Effective for Weight Loss in T1D and Obesity

Remibrutinib for CSU Shows Sustained Efficacy at 1 Year

Kissing may have evolved in an ape ancestor 21 million years ago

Sesame Allergy Study Compares Oral Food Challenge Methods

Biomass Cooking Pollution Not Linked to Pneumonia in Infants

Automatic Doors May Raise Risk for Injury Among Older Adults

GLP-1 RAs Effective for Weight Loss in T1D and Obesity

Remibrutinib for CSU Shows Sustained Efficacy at 1 Year

Kissing may have evolved in an ape ancestor 21 million years ago

Sesame Allergy Study Compares Oral Food Challenge Methods

What’s in the New Settlement Against OxyContin-Maker Purdue and the Sackler Family

Racial Disparities in C-Sections Persist Despite Overall Decrease

Categories

Archives